Randomized Control Study of Capecitabine vs. S-1 in Unresectable or Recurrent Breast Cancer Patients.
Phase of Trial: Phase II
Latest Information Update: 12 May 2016
At a glance
- Drugs Gimeracil/oteracil/tegafur (Primary) ; Capecitabine
- Indications Advanced breast cancer
- Focus Therapeutic Use
- 05 Jun 2013 Primary endpoint 'Progression-free-survival-duration' has been met.
- 04 Jun 2013 Results presented at the 49th Annual Meeting of the American Society of Clinical Oncology.
- 25 May 2013 Status changed from active, no longer recruiting to completed.